Rezaee Mohammad Ahangarzadeh, Abdinia Babak
From the Tabriz Infectious Diseases and Tropical Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (MAR) and Department of Pediatrics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran (BA).
Medicine (Baltimore). 2015 Sep;94(39):e1606. doi: 10.1097/MD.0000000000001606.
Urinary tract infection (UTI) is 1 of the most common bacterial diseases in children with a considerable resistance to antimicrobials. This 5 years prospective study was carried out to determine the frequency of isolation and antimicrobial resistance patterns of uropathogens among children subjected to urine culture at Tabriz Children Educational-Health Care Center, in the northwest of Iran. Organisms were isolated using standard culture techniques. Frequency of UTI among children examined by urine culture was 3.6%. The isolated bacteria were Escherichia coli (71.4%), followed by Klebsiella spp. (9.6%), Enterococcus spp. (6.4%), Pseudomonas aeruginosa (4.2%), Serratia spp. (4.2%), and Enterobacter spp. (4.2%). E coli resistance levels were 11% for nitrofurantoin, 15% for ciprofloxacin, 25% for nalidixic acid, and 30% to 75% for amikacin, gentamicin, ceftriaxone, ceftizoxime, cefotaxime, and co-trimoxazole. Among the tested antibiotics, ciprofloxacin, showed the highest activity (100%) against Klebsiella and P aeruginosa isolates followed by amikacin, nalidixic acid, and gentamicin. Overall, the highly active antibiotic against Gram-negative and Gram-positive organisms was amikacin and then ciprofloxacin. On the other hand, the empirical initial therapy with co-trimoxazole and third-generation cephalosporins would be inadequate for more cases of UTI in the study area. Moreover, susceptibility testing should be carried out on all clinical isolates, and the empirical antibiotic treatment changed accordingly.
尿路感染(UTI)是儿童中最常见的细菌性疾病之一,且对抗菌药物具有相当的耐药性。这项为期5年的前瞻性研究旨在确定伊朗西北部大不里士儿童教育保健中心接受尿培养的儿童中尿路病原体的分离频率和抗菌耐药模式。采用标准培养技术分离菌株。接受尿培养检查的儿童中UTI的发生率为3.6%。分离出的细菌依次为大肠埃希菌(71.4%)、克雷伯菌属(9.6%)、肠球菌属(6.4%)、铜绿假单胞菌(4.2%)、沙雷菌属(4.2%)和肠杆菌属(4.2%)。大肠埃希菌对呋喃妥因的耐药率为11%,对环丙沙星为15%,对萘啶酸为25%,对阿米卡星、庆大霉素、头孢曲松、头孢唑肟、头孢噻肟和复方新诺明的耐药率为30%至75%。在所测试的抗生素中,环丙沙星对克雷伯菌和铜绿假单胞菌分离株的活性最高(100%),其次是阿米卡星、萘啶酸和庆大霉素。总体而言,对革兰氏阴性和革兰氏阳性菌活性最高的抗生素是阿米卡星,其次是环丙沙星。另一方面,在研究区域,复方新诺明和第三代头孢菌素的经验性初始治疗对更多UTI病例将是不足的。此外,应对所有临床分离株进行药敏试验,并相应改变经验性抗生素治疗。